New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022.

Front Pharmacol · 2022 · PMC9742490 · PMID 36518658

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

Although the primary efficacy analysis failed to reach statistical significance, the decline in SVC, ALSFRS-R and muscle strength mega-score of the Reldesemtiv group was slower than that of the placebo group.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.